ArticleBritish journal of cancer2026
A Phase 1/2 study of ontorpacept (TTI-621) in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcoma.
Sujana Movva et al.PubMed ↗Publisher ↗
No numbers read from the abstract.